Clinical Trials Browser

Peripheral Nervous System Diseases

NCT07303816 2025-12-26

STAT-CAT

Phase 4 Not yet recruiting

4,000 enrolled

Classical hematology

Neoplasms, Pulmonary Embolism, Venous Thromboembolism

NCT07254221 2025-12-10

ROSUBREAST

Phase 4 Not yet recruiting

400 enrolled

Breast

Breast Neoplasms, Cardiotoxicity

NCT04491643 2025-08-11

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Phase 2 Completed

48 enrolled

Gynecologic

Endometrial Neoplasms

NCT06102863 2025-04-29

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

Phase 2 Recruiting

38 enrolled

Gynecologic

Endometrial Hyperplasia, Endometrial Neoplasms

NCT04542382 2025-03-30

BCRPmarker

Phase 1 Completed

11 enrolled

Healthy Volunteers

NCT03127631 2025-01-31

RADICALPC

Phase NA Recruiting

6,000 enrolled

Genitourinary

Cardiovascular Diseases, Prostatic Neoplasms

NCT03532139 2025-01-23

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Phase 2 Completed

24 enrolled

Gynecologic

Ovarian Neoplasms

NCT05338723 2024-02-28

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Phase 3 Completed

50 enrolled

Breast

Breast Neoplasms

NCT02569645 2022-07-20

Rosuvastatin in the Treatment of Rectal Cancer

Phase 2 Completed

45 enrolled

Gastrointestinal

Rectal Neoplasms

NCT04776889 2021-03-02

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Phase 4 Completed

70 enrolled

Genitourinary

Prostatic Neoplasms, Hypoalphalipoproteinemias

NCT00966472 2020-04-21

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Phase 1 Completed

24 enrolled

Thoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT01299038 2020-02-05

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Phase 2 Completed

20 enrolled 4 charts

Breast

Breast Neoplasms

NCT02114697 2018-09-11

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

Phase 4 Terminated

9 enrolled 6 charts

Cardiovascular Diseases, Ischemic Attack, Transient, Stroke, Atherosclerosis

NCT01051401 2018-08-01

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

Phase 1 Terminated

5 enrolled

Breast

Breast Neoplasms

NCT01524653 2018-07-10

DISOLVE

Phase 2 Completed

38 enrolled

Classical hematology

Neoplasm Metastasis, Neoplasms, Venous Thrombosis, Venous Thromboembolism

NCT02483871 2017-06-05

Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy

Phase 1 Withdrawn

Breast

Breast Neoplasms

Clinical Trials

Neuroprotection of Memantine and Rosuvastatin

STAT-CAT

ROSUBREAST

Megestrol Acetate Plus Rosuvastatin in Young Women With Early Endometrial Carcinoma

Progesterone Therapeutic Regimen Plus Statins in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia

BCRPmarker

RADICALPC

Pilot Study of Rosuvastatin and Enoxaparin Thromboprophylaxis Following Ovarian Cancer Surgery (O-STAT Study)

Possible Protective Effect of Rosuvastatin in Chemotherapy-induced Cardiotoxicity in HER2 Positive Breast Cancer Patients

Rosuvastatin in the Treatment of Rectal Cancer

The Prognosis of Lipid Reprogramming With Rosuvastatin, in Castrated Egyptian Prostate Cancer Patients

Phase I Study of a Statin + Erlotinib for Advanced Solid Malignancies With Focus on Squamous Cell Carcinomas and NSCLC

Rosuvastatin to Lower Circulating Tissue Factor Bearing Microparticles in Metastatic Breast Cancer

Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging

Rosuvastatin in Treating Women With Cardiovascular Complications Who Are Undergoing Chemotherapy For Breast Cancer

DISOLVE

Dose Optimization of Rosuvastatin in Early Stage and Metastatic Estrogen Receptor Positive Breast Cancer Patients on Endocrine Therapy